Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?

view original post

Moderna, Xeris Biopharma, and Vir Biotechnology shares surged to annual highs on Friday as Wall Street optimism grew and markets awaited trial data.